Delivery Order SPE2DB20D3103-SPE2DB23FP1H7
Award Date 7/26/23
Potential Completion Date 7/27/23
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The $11,466.00 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has an ultimate completion date of August 20, 2024, is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held...
- This federal contract award is for the delivery of pharmaceutical products, specifically the medication Multihance 529 mg/ml vial 10ml, to the Defense Logistics Agency (DLA) for a total ceiling value of $3,054.00. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop...
- This federal contract award is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,989.50 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves to provide a wide range of pharmaceutical...
- This federal contract award is for the delivery of MULTIHANCE 529 MG/ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,298.40 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also a significant federal contractor. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
- This federal contract award is for the delivery of Multihance 529 mg/ml vial, 10 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- This contract award, valued at $3,091.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of MULTIHANCE 529 MG/ML VIAL 10ML. The contract is a delivery order, with a firm fixed price pricing type and an ultimate completion date of June 23, 2022. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which is the parent company. Cencora, Inc. holds a...
- This federal contract award, with an ID of SPE2DB20D3103|SPE2DB22FN9D3, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML, a medical product, with an ultimate completion date of June 15, 2022 and a ceiling value of $5,989.50. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,659.26, is a Delivery Order that covers the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and an ultimate completion date of November 20, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $2,866.50, is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML, a medical supply product. The contract is a Delivery Order type with a Firm Fixed Price pricing arrangement, and has an ultimate completion date of June 11, 2024. Amerisourcebergen Drug Corp's Corporate Office Division, which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Multihance 529 mg/ml vials (20 ml units) under a firm fixed price contract with a ceiling value of $9,105.30. The award was made on November 20, 2025, with an ultimate completion date of November 21, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement...